Kathryn F Sykes

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Obstructive Sleep Apnea

Peripheral Blood

Top Venues

PLoS neglected tropical diseases

Journal of translational medicine

Calviri, Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Calviri, Inc Sep 03 2019

United States

Vice Pres Research & Product Development

Publications

Luhui Shen, Justin R Brown, Stephen Albert Johnston, Mehmet Altan, Kathryn F Sykes
Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens. Journal of translational medicine 21 (1) (2023)
Luhui Shen, Zhan-Gong Zhao, John C Lainson, Justin R Brown, Kathryn F Sykes, Stephen Albert Johnston, Chris W Diehnelt
Production of high-complexity frameshift neoantigen peptide microarrays. RSC advances 10 (50) (2020)
Michael Rowe, Jonathan Melnick, Robert Gerwien, Joseph B Legutki, Jessica Pfeilsticker, Theodore M Tarasow, Kathryn F Sykes
An ImmunoSignature test distinguishes Trypanosoma cruzi, hepatitis B, hepatitis C and West Nile virus seropositivity among asymptomatic blood donors. PLoS neglected tropical diseases 11 (9) (2017)